FDAFDA · Food and drugs·Recall number D-0771-2026
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Published August 26, 2026 · Recall initiated: August 7, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP deviations: tablets with black specks.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CARBAMAZEPINE
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- USA Nationwide
- Lot
- Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.